InvestorsHub Logo
Followers 834
Posts 119888
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Sunday, 02/28/2021 7:22:56 PM

Sunday, February 28, 2021 7:22:56 PM

Post# of 1051
Thanks to the COVID-19 vaccine, JNJ may end up getting pretty good value for its 2010 acquisition of Crucell, N.V. — a deal in which JNJ paid $2.4B for the 82% of Crucell it did not already own (#msg-55228522).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JNJ News